PAPP-A in cardiac and non-cardiac conditions

Clinica Chimica Acta

Volumn 417, Issue , 2013, Pages 67-72

  Li, Yuehua ^a   Zhou, Chenghui ^a   Zhou, Xianliang ^a   Song, Lei ^a   Hui, Rutai ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Atherosclerosis; Biomarker; Cancer; End stage renal disease; Pregnancy associated plasma protein A

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ACUTE CORONARY SYNDROME; AGING; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; DRUG MEGADOSE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LIFESPAN; LOW DRUG DOSE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; RISK REDUCTION; SYSTEMIC DISEASE;

AGING; ANIMALS; BIOLOGICAL MARKERS; DISEASE; HUMANS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;

MUS;

EID: 84872483366     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.12.006     Document Type: Review

References (72)

1. Boldt H.B., Conover C.A. Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs. Growth Horm IGF Res 2007, 17:10-18.
2. Bayes-Genis A., Conover C.A., Schwartz R.S. The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 2000, 86:125-130.
3. Holzenberger M., Dupont J., Ducos B., et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003, 421:182-187.
4. Harrington S.C., Simari R.D., Conover C.A. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Circ Res 2007, 100:1696-1702.
5. Bartke A. Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging. Endocrinology 2005, 146:3718-3723.
6. Conover C.A. Key questions and answers about pregnancy-associated plasma protein-A. Trends Endocrinol Metab TEM 2012, 23:242-249.
7. Conover C.A. PAPP-A: a new anti-aging target?. Aging Cell 2010, 9:942-946.
8. Conover C.A. Role of PAPP-A in aging and age-related disease. Exp Gerontol 2012, 10.1016/j.exger.2012.06.017.
9. Wapner R., Thom E., Simpson J.L., et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003, 349:1405-1413.
10. Lawrence J.B., Oxvig C., Overgaard M.T., et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A 1999, 96:3149-3153.
11. Gyrup C., Oxvig C. Quantitative analysis of insulin-like growth factor-modulated proteolysis of insulin-like growth factor binding protein-4 and -5 by pregnancy-associated plasma protein-A. Biochemistry 2007, 46:1972-1980.
12. Delafontaine P., Song Y.H., Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 2004, 24:435-444.
13. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008, 8:915-928.
14. Conover C.A., Bale L.K., Overgaard M.T., et al. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 2004, 131:1187-1194.
15. Bale L.K., Conover C.A. Disruption of insulin-like growth factor-II imprinting during embryonic development rescues the dwarf phenotype of mice null for pregnancy-associated plasma protein-A. J Endocrinol 2005, 186:325-331.
16. Qin X., Wergedal J.E., Rehage M., et al. Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo. Endocrinology 2006, 147:5653-5661.
17. Phang D., Rehage M., Bonafede B., et al. Inactivation of insulin-like-growth factors diminished the anabolic effects of pregnancy-associated plasma protein-A (PAPP-A) on bone in mice. Growth Horm IGF Res 2010, 20:192-200.
18. Rehage M., Mohan S., Wergedal J.E., et al. Transgenic overexpression of pregnancy-associated plasma protein-A increases the somatic growth and skeletal muscle mass in mice. Endocrinology 2007, 148:6176-6185.
19. Mazerbourg S., Overgaard M.T., Oxvig C., et al. Pregnancy-associated plasma protein-A (PAPP-A) in ovine, bovine, porcine, and equine ovarian follicles: involvement in IGF binding protein-4 proteolytic degradation and mRNA expression during follicular development. Endocrinology 2001, 142:5243-5253.
20. Brogan R.S., Mix S., Puttabyatappa M., VandeVoort C.A., Chaffin C.L. Expression of the insulin-like growth factor and insulin systems in the luteinizing macaque ovarian follicle. Fertil Steril 2010, 93:1421-1429.
21. Chen B.K., Leiferman K.M., Pittelkow M.R., Overgaard M.T., Oxvig C., Conover C.A. Localization and regulation of pregnancy-associated plasma protein a expression in healing human skin. J Clin Endocrinol Metab 2003, 88:4465-4471.
22. Bulut I., Coskun A., Ciftci A., et al. Relationship between pregnancy-associated plasma protein-A and lung cancer. Am J Med Sci 2009, 337:241-244.
23. Conover C.A., Bale L.K., Mader J.R., Mason M.A., Keenan K.P., Marler R.J. Longevity and age-related pathology of mice deficient in pregnancy-associated plasma protein-A. J Gerontol A Biol Sci Med Sci 2010, 65:590-599.
24. Qin Q.P., Kokkala S., Lund J., Tamm N., Voipio-Pulkki L.M., Pettersson K. Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy. Clin Chem 2005, 51:75-83.
25. Resch Z.T., Chen B.K., Bale L.K., Oxvig C., Overgaard M.T., Conover C.A. Pregnancy-associated plasma protein a gene expression as a target of inflammatory cytokines. Endocrinology 2004, 145:1124-1129.
26. Conover C.A., Bale L.K., Harrington S.C., Resch Z.T., Overgaard M.T., Oxvig C. Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol. Am J Physiol Cell Physiol 2006, 290:C183-C188.
27. Resch Z.T., Oxvig C., Bale L.K., Conover C.A. Stress-activated signaling pathways mediate the stimulation of pregnancy-associated plasma protein-A expression in cultured human fibroblasts. Endocrinology 2006, 147:885-890.
28. Ortiz C.O., Chen B.K., Bale L.K., Overgaard M.T., Oxvig C., Conover C.A. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts. J Bone Miner Res 2003, 18:1066-1072.
29. Conover C.A., Harrington S.C., Bale L.K. Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells. Growth Horm IGF Res 2008, 18:213-220.
30. Bayes-Genis A., Conover C.A., Overgaard M.T., et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001, 345:1022-1029.
31. Sangiorgi G., Mauriello A., Bonanno E., et al. Pregnancy-associated plasma protein-A is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events. J Am Coll Cardiol 2006, 47:2201-2211.
32. Lund J., Qin Q.P., Ilva T., et al. Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003, 108:1924-1926.
33. Conover C.A., Mason M.A., Bale L.K., et al. Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development. Am J Physiol Heart Circ Physiol 2010, 299:H284-H291.
34. Resch Z.T., Simari R.D., Conover C.A. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury. Endocrinology 2006, 147:5634-5640.
35. Conover C.A., Harrington S.C., Bale L.K., Oxvig C. Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophages. Am J Physiol Heart Circ Physiol 2007, 292:H994-H1000.
36. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Simoons M.L., Zeiher A.M. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005, 45:229-237.
37. Lund J., Qin Q.P., Ilva T., et al. Pregnancy-associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI). Ann Med 2006, 38:221-228.
38. Iversen K.K., Teisner A.S., Teisner B., et al. Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction. Am J Cardiol 2008, 101:1389-1394.
39. Iversen K.K., Teisner A.S., Teisner B., et al. Pregnancy associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome. Clin Biochem 2009, 42:828-834.
40. Lund J., Wittfooth S., Qin Q.P., et al. Free vs total pregnancy-associated plasma protein A (PAPP-A) as a predictor of 1-year outcome in patients presenting with non-ST-elevation acute coronary syndrome. Clin Chem 2010, 56:1158-1165.
41. Mei W.Y., Du Z.M., Zhao Q., et al. Pregnancy-associated plasma protein predicts outcomes of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome. Heart Lung 2011, 40:e78-e83.
42. Iversen K.K., Teisner A.S., Teisner B., et al. Pregnancy-associated plasma protein A in non-cardiac conditions. Clin Biochem 2008, 41:548-553.
43. Consuegra-Sanchez L., Petrovic I., Cosin-Sales J., Holt D.W., Christiansen M., Kaski J.C. Prognostic value of circulating pregnancy-associated plasma protein-A (PAPP-A) and proform of eosinophil major basic protein (pro-MBP) levels in patients with chronic stable angina pectoris. Clin Chim Acta 2008, 391:18-23.
44. Elesber A.A., Conover C.A., Denktas A.E., et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J 2006, 27:1678-1684.
45. Iversen K.K., Dalsgaard M., Teisner A.S., et al. Usefulness of pregnancy-associated plasma protein A in patients with acute coronary syndrome. Am J Cardiol 2009, 104:1465-1471.
46. Iversen K.K., Dalsgaard M., Teisner A.S., et al. Pregnancy-associated plasma protein-A, a marker for outcome in patients suspected for acute coronary syndrome. Clin Biochem 2010, 43:851-857.
47. Iversen K.K., Teisner B., Winkel P., et al. Pregnancy associated plasma protein-A as a marker for myocardial infarction and death in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial. Atherosclerosis 2011, 214:203-208.
48. Kavsak P.A., Wang X., Henderson M., Ko D.T., MacRae A.R., Jaffe A.S. PAPP-A as a marker of increased long-term risk in patients with chest pain. Clin Biochem 2009, 42:1012-1018.
49. Li X.P., Zhou S.H., Tang J.J., et al. Association between plasma pregnancy-associated plasma protein a and restenosis after percutaneous coronary angioplasty. Circ J 2008, 72:729-733.
50. Brugger-Andersen T., Aarsetoy H., Grundt H., Staines H., Nilsen D.W. The long-term prognostic value of multiple biomarkers following a myocardial infarction. Thromb Res 2008, 123:60-66.
51. Bonaca M.P., Scirica B.M., Sabatine M.S., et al. Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes. J Am Coll Cardiol 2012, 60:332-338.
52. Yuehua Li, Chenghui Zhou, Xianliang Zhou, Li L, Hui R. Pregnancy-associated plasma protein A predicts adverse clinical outcomes in patients with coronary heart disease: a systematic review and meta-analysis. Unpublished 2012.
53. Mueller T., Dieplinger B., Poelz W., Haltmayer M. Increased pregnancy-associated plasma protein-A as a marker for peripheral atherosclerosis: results from the Linz Peripheral Arterial Disease Study. Clin Chem 2006, 52:1096-1103.
54. Aso Y., Okumura K., Wakabayashi S., Takebayashi K., Taki S., Inukai T. Elevated pregnancy-associated plasma protein-a in sera from type 2 diabetic patients with hypercholesterolemia: associations with carotid atherosclerosis and toe-brachial index. J Clin Endocrinol Metab 2004, 89:5713-5717.
55. Heider P., Pfaffle N., Pelisek J., et al. Is serum pregnancy-associated plasma protein A really a potential marker of atherosclerotic carotid plaque stability?. Eur J Vasc Endovasc Surg 2010, 39:668-675.
56. Pellitero S., Reverter J.L., Pizarro E., et al. Pregnancy-associated plasma protein-a levels are related to glycemic control but not to lipid profile or hemostatic parameters in type 2 diabetes. Diabetes Care 2007, 30:3083-3085.
57. Pellitero S., Reverter J.L., Granada M.L., et al. Association of the IGF1/pregnancy-associated plasma protein-A system and adipocytokine levels with the presence and the morphology of carotid plaques in type 2 diabetes mellitus patients with stable glycaemic control. Eur J Endocrinol 2009, 160:925-932.
58. Miedema M.D., Conover C.A., MacDonald H., et al. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy. Am J Cardiol 2008, 101:35-39.
59. Ostadal P., Alan D., Vejvoda J., et al. Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial). Trials 2010, 11:61.
60. Conover C.A., Bale L.K. Loss of pregnancy-associated plasma protein A extends lifespan in mice. Aging Cell 2007, 6:727-729.
61. Austad S. Advances in vertebrate aging research 2007. Aging Cell 2008, 7:119-124.
62. Vallejo A.N., Michel J.J., Bale L.K., Lemster B.H., Borghesi L., Conover C.A. Resistance to age-dependent thymic atrophy in long-lived mice that are deficient in pregnancy-associated plasma protein A. Proc Natl Acad Sci U S A 2009, 106:11252-11257.
63. Swindell W.R., Masternak M.M., Bartke A. In vivo analysis of gene expression in long-lived mice lacking the pregnancy-associated plasma protein A (PappA) gene. Exp Gerontol 2010, 45:366-374.
64. Conover C.A., Mason M.A., Levine J.A., Novak C.M. Metabolic consequences of pregnancy-associated plasma protein-A deficiency in mice: exploring possible relationship to the longevity phenotype. J Endocrinol 2008, 198:599-605.
65. Samani A.A., Yakar S., LeRoith D., Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 2007, 28:20-47.
66. Kalli K.R., Chen B.K., Bale L.K., et al. Pregnancy-associated plasma protein-A (PAPP-A) expression and insulin-like growth factor binding protein-4 protease activity in normal and malignant ovarian surface epithelial cells. Int J Cancer 2004, 110:633-640.
67. Ryan A.J., Napoletano S., Fitzpatrick P.A., Currid C.A., O'Sullivan N.C., Harmey J.H. Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer. Br J Cancer 2009, 101:278-286.
68. Coskun A., Duran S., Apaydin S., Bulut I., M.S. Pregnancy-associated plasma protein-A: evaluation of a new biomarker in renal transplant patients. Transplant Proc 2007, 39:3072-3076.
69. Sancho A., Pastor M.C., Bayes B., et al. Posttransplant inflammation associated with onset of chronic kidney disease. Transplant Proc 2010, 42:2896-2898.
70. Lauzurica R., Pastor C., Bayes B., Hernandez J.M., Romero R. Pretransplant pregnancy-associated plasma protein-a as a predictor of chronic allograft nephropathy and posttransplant cardiovascular events. Transplantation 2005, 80:1441-1446.
71. Kalousova M., Horejsi M., Fialova L., et al. Increased levels of pregnancy-associated plasma protein A are associated with mortality in hemodialysis patients: preliminary results. Blood Purif 2004, 22:298-300.
72. Etter C., Straub Y., Hersberger M., et al. Pregnancy-associated plasma protein-A is an independent short-time predictor of mortality in patients on maintenance haemodialysis. Eur Heart J 2010, 31:354-359.